By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Biotechnology Industry Organization (BIO) 

1225 Eye Street, NW
Suite 400
Washington  D.C.  20005-5958  U.S.A.
Phone: 202-962-9200 Fax: 202-962-9201


SEARCH JOBS

The Biotechnology Industry Organization (BIO) is the largest trade organization to serve and represent the emerging biotechnology industry in the United States and around the globe. The organization's leadership and service-oriented guidance have helped advance the industry and bring the benefits of biotechnology to the people of the world.

As the leading voice for the biotechnology industry, BIO represents companies of all sizes engaged in the development of products and services in the areas of agriculture, biomedicine, diagnostics, food, energy and environmental applications. Though biotechnology's future is bright, the industry's success will depend on the commitment, energy and direction of the group that helps guide its growth. BIO is a vital forum and an invaluable focal point to bring together the resources and expertise to meet critical challenges and serve the needs of its members.

Key Statistics


Email: info@bio.org
Ownership: Private

Web Site: BIO
Employees:
Symbol: 
 





Collaborations

CHI 





Company News
Lyonbiopole Announces Success At BIO 2015 7/30/2015 1:09:06 PM
BIO Joins Coalition Cautioning Against Further Restructuring Of Japan’s Pharmaceutical Pricing Structure 7/29/2015 10:33:35 AM
The 2015 BIO World Congress On Industrial Biotechnology Closes In Montreal - Event Sets New Record For Partnering Meetings 7/23/2015 11:00:55 AM
BIO CEO Participates In Stakeholder Forum On The Biorefinery, Renewable Chemical, And Biobased Product Manufacturing Assistance Program 7/17/2015 7:38:34 AM
Alexandria Real Estate Equities, Inc. CEO Joel Marcus Appointed To BIO Board 7/14/2015 10:53:50 AM
BIO2015 EXCLUSIVE: BioSpace (DHX)’s Insider Profile of Neovacs SA 7/9/2015 5:26:35 PM
BIO2015: Eli Lilly (LLY) Expands Scope of Open Innovation Drug Discovery Program, Exec Tells BioSpace (DHX) 7/9/2015 10:18:19 AM
BIO Opposes Brat Amendment To Make Mandatory NIH Funding Discretionary 7/9/2015 8:01:34 AM
BIO World Congress On Industrial Biotechnology Special Topic Workshops To Focus On Current Investment Trends 7/8/2015 10:49:48 AM
Syros Pharmaceuticals Announces Appointment Of CEO Nancy Simonian To BIO Board 7/6/2015 8:54:58 AM
12345678910...
//-->